300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Social Impact
Oil and Gas
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Franchise
Social Media
Mobile Advertising
Android
Non Profit
Internet
Sustainability
Enterprise
Hardware
Biotech
Impact
Community
Proptech
Media (Entertainment)
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Spain
Albania
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Angola
Europe
Cyprus
Peru
Slovenia
San Marino
Ukraine
Qatar
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Advantech Capital, VC Fund

Advantech Capital

VC Fund

Central, Hong Kong

Advantech Capital is a private equity fund, focused on innovation-driven growth capital in China.

Total investments:
41
Last investment:
Lead investor:
49%
Fund size:
$350M
Last fund:

Last updated:

Industries Advantech Capital invests in

BiotechnologyPharmaceuticalHealth CareMedicalTherapeutics

Stages Advantech Capital invests in

Series BSeries ASeries CSeries DSeries E

Countries Advantech Capital invests in

ChinaUnited States

Contacts

NameEmailPhoneSocials
Hebert Kee Chan Pang Hebert Kee Chan Pang
Jennifer Jin Jennifer Jin
Benjamin Qiu Benjamin Qiu

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Biotechnology 14 (34%)
  • Pharmaceutical 11 (27%)
  • Health Care 10 (24%)
  • Medical 7 (17%)
  • Therapeutics 6 (15%)
See all 55 industries →

Stage

  • Series B 16 (39%)
  • Series A 9 (22%)
  • Series C 3 (7%)
  • Series D 2 (5%)
  • Series E 2 (5%)
See all 9 stages →

Country

  • China 26 (63%)
  • United States 6 (15%)

Team

NameTitleInvestmentsLinksEmail
Hebert Kee Chan Pang
Hebert Kee Chan Pang Director
Director Total investments: 0 Find email
Jennifer Jin
Jennifer Jin Partner
Partner Total investments: 1
Find email
Benjamin Qiu
Benjamin Qiu Partner
Partner Total investments: 6
Find email
Jianming Yu
Jianming Yu Founder, Managing Partner
Founder, Managing Partner Total investments: 1
Find email
Jianming Yu
Jianming Yu Founder, Managing Partner
Founder, Managing Partner Total investments: 1
Find email

Investments

CompanyDescriptionRoundLinks
Spot Biosystems Spot Biosystems
Spot BioSystems is a bioengineering firm that specializes in personalized cancer treatments. The company's headquarters are in Palo Alto, California. $40M / Venture - Series Unknown / Jun 17, 2026
ELITE Technology ELITE Technology
Elite's seven-axis collaborative robot uses the latest deep neural network (DNN) technology to identify irregularly shaped objects and accurately capture them. Through the fusion of 2D and 3D data, the accuracy requirements of the depth vision sensor are reduced, the success rate of the capture is improved, the versatility of the grabbingsystem is enhanced, and the hybrid object capture is supported. The system can be widely used in 3C, logistics, retail, catering and other industries. Series C / Mar 11, 2022
CureGenetics CureGenetics
Cure Genetics is a biotechnology company developing cutting-edge applications of technologies in innovative medicines and molecular diagnostics for the next-generation treatment of cancers and genetic diseases. $60M / Series B / Jan 05, 2022
Mojo Vision Mojo Vision
Mojo Vision is a developer of augmented reality products and platforms intended to invent the future of computing. The company has developed a smart contact lens with a built-in display that gives timely information without interrupting the focus and delivers immediate, powerful, and relevant information without the intrusions of today'smobile devices, enabling users to connect with others at a glance, anytime, anywhere handsfree.Mojo Vision was founded in 2015 and headquartered in Saratoga, California. $45M / Series B / Jan 04, 2022
Innoforce Pharmaceuticals Innoforce Pharmaceuticals
Innoforce is a biopharma manufacturing firm that facilitates the development and commercialization of innovative medicines. $58.8M / Series A / Dec 06, 2021
Ablaze Pharmaceuticals Ablaze Pharmaceuticals
Ablaze Pharma is a clinical stage bio-pharmaceutical company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients. $75M / Series A / Nov 29, 2021
Zhimeng Biopharma Zhimeng Biopharma
Zhimeng is also actively developing novel small molecule drugs to treat neurological diseases, such as epilepsy, pains and strokes. $54.7M / Series B / Nov 08, 2021
Boan Biotech Boan Biotech
Boan Biotech is a biopharmaceutical company developing therapeutic antibodies with a focus on key therapeutic areas including oncology, metabolism, autoimmunity, and ophthalmology. $18.8M / Series B / Oct 01, 2021
Onconano Medicine Onconano Medicine
OncoNano Medicine is a biotech company that develops nanotechnology-enabled fluorescent probes to help cancer surgeons visualize tumors during surgery, allowing them to excise tumors more precisely. The fluorescent sensor targets the different pH signals, thus making them glow so they are easier to distinguish from normal tissue.OncoNano Medicineis a UTSW spinoff company based in Dallas, Texas. $50M / Series B / Jun 17, 2021
Zhuanzhuan Zhuanzhuan
Zhuanzhuan is an online marketplace on which users can buy and sell secondhand goods. Moreover, Zhuanzhuan operates as a goods trading unit of China's largest online marketplace, 58.com Launched in November 2015, the company is headquartered in China. $100M / Series D / Jun 17, 2021
See all 41 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Social Impact
Oil and Gas
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Franchise
Social Media
Mobile Advertising
Android
Non Profit
Internet
Sustainability
Enterprise
Hardware
Biotech
Impact
Community
Proptech
Media (Entertainment)
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Spain
Albania
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Angola
Europe
Cyprus
Peru
Slovenia
San Marino
Ukraine
Qatar
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Advantech Capital invest in?

Advantech Capital invests primarily in Biotechnology, Pharmaceutical and Health Care startups, most often at Series B and Series A stage. Most of the 41 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Advantech Capital?

Public channels for Advantech Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Advantech Capital?

The team at Advantech Capital includes Hebert Kee Chan Pang (Director), Jennifer Jin (Partner) and Benjamin Qiu (Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Advantech Capital Advantech Capital Find emails